Ion channels as drug targets in central nervous system disorders
- PMID: 23409712
- PMCID: PMC3706965
- DOI: 10.2174/0929867311320100005
Ion channels as drug targets in central nervous system disorders
Abstract
Ion channel targeted drugs have always been related with either the central nervous system (CNS), the peripheral nervous system, or the cardiovascular system. Within the CNS, basic indications of drugs are: sleep disorders, anxiety, epilepsy, pain, etc. However, traditional channel blockers have multiple adverse events, mainly due to low specificity of mechanism of action. Lately, novel ion channel subtypes have been discovered, which gives premises to drug discovery process led towards specific channel subtypes. An example is Na(+) channels, whose subtypes 1.3 and 1.7-1.9 are responsible for pain, and 1.1 and 1.2 - for epilepsy. Moreover, new drug candidates have been recognized. This review is focusing on ion channels subtypes, which play a significant role in current drug discovery and development process. The knowledge on channel subtypes has developed rapidly, giving new nomenclatures of ion channels. For example, Ca(2+)s channels are not any more divided to T, L, N, P/Q, and R, but they are described as Ca(v)1.1-Ca(v)3.3, with even newer nomenclature α1A-α1I and α1S. Moreover, new channels such as P2X1-P2X7, as well as TRPA1-TRPV1 have been discovered, giving premises for new types of analgesic drugs.
Figures
Similar articles
-
Ligand action on sodium, potassium, and calcium channels: role of permeant ions.Trends Pharmacol Sci. 2013 Mar;34(3):154-61. doi: 10.1016/j.tips.2013.01.002. Epub 2013 Feb 1. Trends Pharmacol Sci. 2013. PMID: 23375737
-
Recent advances in the modulation of voltage-gated ion channels for the treatment of epilepsy.Curr Drug Targets CNS Neurol Disord. 2002 Feb;1(1):81-104. doi: 10.2174/1568007023339463. Curr Drug Targets CNS Neurol Disord. 2002. PMID: 12769636 Review.
-
Small molecules targeting sodium and calcium channels for neuropathic pain.Curr Opin Drug Discov Devel. 2009 Jul;12(4):543-61. Curr Opin Drug Discov Devel. 2009. PMID: 19562650 Review.
-
The structure and ion channel activity of 6-benzylamino-3-hydroxyhexa-cyclo[6.5.0.0(3,7).0(4,12).0(5,10).0(9,13]tridecane.Arch Pharm (Weinheim). 2003 Apr;336(2):127-33. doi: 10.1002/ardp.200390009. Arch Pharm (Weinheim). 2003. PMID: 12761766
-
Two tarantula peptides inhibit activation of multiple sodium channels.Biochemistry. 2002 Dec 17;41(50):14734-47. doi: 10.1021/bi026546a. Biochemistry. 2002. PMID: 12475222
Cited by
-
Design, In silico Screening, Synthesis, Characterisation and DFT-based Electronic Properties of Dihydropyridine-based Molecule as L-type Calcium Channel Blocker.Curr Comput Aided Drug Des. 2024;20(7):1130-1146. doi: 10.2174/0115734099273719231005062524. Curr Comput Aided Drug Des. 2024. PMID: 39354859
-
Voltage Gated Ion Channels and Sleep.J Membr Biol. 2024 Oct 1. doi: 10.1007/s00232-024-00325-0. Online ahead of print. J Membr Biol. 2024. PMID: 39354150 Review.
-
Ion channel inhibition by targeted recruitment of NEDD4-2 with divalent nanobodies.bioRxiv [Preprint]. 2024 May 31:2024.05.28.596281. doi: 10.1101/2024.05.28.596281. bioRxiv. 2024. PMID: 38854018 Free PMC article. Preprint.
-
Recent Advances in Computer-Aided Structure-Based Drug Design on Ion Channels.Int J Mol Sci. 2023 May 25;24(11):9226. doi: 10.3390/ijms24119226. Int J Mol Sci. 2023. PMID: 37298178 Free PMC article. Review.
-
High-throughput combined voltage-clamp/current-clamp analysis of freshly isolated neurons.Cell Rep Methods. 2023 Jan 12;3(1):100385. doi: 10.1016/j.crmeth.2022.100385. eCollection 2023 Jan 23. Cell Rep Methods. 2023. PMID: 36814833 Free PMC article.
References
-
- Anger T, Madge DJ, Mulla M, Riddall D. Medicinal chemistry of neuronal voltage-gated sodium channel blockers. J. Med. Chem. 2001;44(2):115–137. - PubMed
-
- Mantegazza M, Curia G, Biagini G, Ragsdale DS, Avoli M. Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders. Lancet Neurol. 2010;9(4):413–424. - PubMed
-
- Chahine M, Chatelier A, Babich O, Krupp JJ. Voltage-gated sodium channels in neurological disorders. CNS Neurol. Disord. Drug Targets. 2008;7(2):144–158. - PubMed
-
- Tarnawa I, Bolcskei H, Kocsis P. Blockers of voltage-gated sodium channels for the treatment of central nervous system diseases. Recent Pat. CNS Drug Discov. 2007;2(1):57–78. - PubMed
-
- Cestèle S, Catterall WA. Molecular mechanisms of neurotoxin action on voltage-gated sodium channels. Biochimie. 2000;82(9-10):883–892. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous